diltiazem has been researched along with atenolol in 104 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (18.27) | 18.7374 |
| 1990's | 41 (39.42) | 18.2507 |
| 2000's | 29 (27.88) | 29.6817 |
| 2010's | 12 (11.54) | 24.3611 |
| 2020's | 3 (2.88) | 2.80 |
| Authors | Studies |
|---|---|
| Gubernator, K; Kansy, M; Senner, F | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
| Caron, G; Ermondi, G | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abdel-Maksoud, MS; Ali, EMH; Ammar, UM; Choi, HS; El-Gamal, MI; Gamal El-Din, MM; Han, DK; Jeon, HR; Kim, G; Kwon, D; Kwon, YJ; Lee, BS; Lee, JK; Lee, KH; Lee, KT; Mersal, KI; Oh, CH; Yoo, KH | 1 |
| Abiko, Y; Ichihara, K; Nasa, Y; Yoshida, R | 1 |
| Conti, CR | 1 |
| Therkelsen, K; Toft, E; Vyberg, M | 1 |
| Applegate, WB; Koch, GG; Luhr, JC; Park, GD; Phillips, HL; Schnaper, H; Schocken, D; Shepherd, AM | 1 |
| Bune, AJ; Cain, MD; Chalmers, J; Morris, MJ; Russell, AE; Tonkin, AL; West, MJ; Wing, LM | 1 |
| Freedman, SB; Kelly, DT; Ogasawara, S; Ram, J | 1 |
| Bigger, JT; Cook, JR; Fleiss, JL; Kleiger, RE; Rolnitzky, LM; Steinman, RC | 1 |
| Berne, C; Lithell, H; Pollare, T | 2 |
| Chalmers, J; Taylor, S; Wing, L | 1 |
| Arita, M; Fujino, T; Fukumoto, T; Ito, M; Ito, S; Kikuchi, Y; Maeda, Y; Saikawa, T; Tsumabuki, S; Yamada, K | 1 |
| Bouckaert, J; Lefebvre, R; Pannier, JL | 1 |
| Hvarfner, A; Lithell, H; Ljunghall, S; Mörlin, C; Pollare, T; Präntare, H | 1 |
| Chapman, KR; Galko, BM; Leenen, FH; Smith, DL | 1 |
| Kohvakka, A; Luurila, OJ; Sundberg, S | 1 |
| Abecia, A; Alegría, E; Castelló, R; Fidalgo, M; Martínez-Caro, D; Merino, A | 1 |
| Slagle, DA | 1 |
| Davies, GJ; el-Tamimi, H; Galassi, AR; Kaski, JC; Maseri, A; Vejar, M | 1 |
| Henry, M; Kay, MM; Viccellio, P | 1 |
| Guth, BD; Lee, JD; Matsuzaki, M; Ross, J; Seitelberger, R; Tajimi, T | 1 |
| Ebihara, A; Hosoda, S; Kumagai, Y; Nakashima, H; Ohashi, K; Shitou, T; Tateishi, T | 1 |
| Gröhn, P; Hämäläinen, L; Härkönen, R; Heikkilä, J; Idänpään-Heikkilä, U; Kohvakka, A; Luurila, OJ; Rytkönen, U; Setälä, M; Sundberg, S | 1 |
| Gordon, NF; Myburgh, DP | 1 |
| Giard, MJ; Josselson, J; Lam, YW; Posner, JN; Saunders, E; Warren, JB; Weir, MR; Zaske, DE | 1 |
| Gallagher, KP; Goldfarb, R; Guth, B; Lee, JD; Matzusaki, M; Ross, J | 1 |
| Bassand, J; Berthout, P; Cardot, JC; Faivre, R; Maurat, JP; Mercier, M; Schipman, C | 1 |
| Wheatley, D | 1 |
| Guth, B; Kemper, WS; Matsuzaki, M; Ross, J; Tajimi, T | 1 |
| Hagihara, T; Kishi, Y; Matsumoto, G; Matsuo, H; Naka, K; Nanjo, K; Ohoshi, T; Sanke, T; Sasaki, H; Sowa, R | 1 |
| Baleynaud, S; Cohen-Solal, A; Gourgon, R; Laperche, T; Sebag, C | 1 |
| Bretnall, AE; Clarke, GS | 1 |
| Daxini, BV; Freedman, SB; Kelly, DT; Noyce, D | 1 |
| Biscione, F; Lanza, GA; Manzoli, A; Natale, A; Santarelli, P | 1 |
| Chrysant, SG; Miller, E | 1 |
| Lambert, CR; Pepine, CJ; Raymenants, E | 1 |
| Derman, WE; Dunbar, F; Haus, M; Lambert, M; Noakes, TD | 1 |
| Deckert, J; Gleiter, CH; Przuntek, H | 1 |
| Bourassa, MG; Chaitman, BR; Davies, RF; Day, P; Deanfield, JE; Geller, NL; Goldberg, AD; Knatterud, GL; McMahon, RP; Pepine, CJ | 1 |
| Bourassa, MG; Chaitman, BR; Davies, RF; Geller, NL; Knatterud, GL; Pepine, CJ; Pratt, C; Rogers, WJ; Sopko, G; Stone, PH | 1 |
| Amado, P; Araújo, V; Carmona, J; Castanheira, J; Nazaré, J | 1 |
| Davies, GJ; Nadazdin, A | 1 |
| Grande, P; Haunsø, S; Pedersen, F; Steffensen, R | 1 |
| Bakris, GL; Sadler, R; Slataper, R; Vicknair, N | 1 |
| Applegate, WB | 1 |
| Cushman, WC; Freis, ED; Fye, C; Gottdiener, J; Hamburger, RJ; Kochar, MS; Lakshman, R; Massie, BM; Materson, BJ; Reda, DJ | 1 |
| Andrews, TC; Conti, CR; Dyrda, I; Frishman, WH; Geller, NL; Goldstein, S; Hill, JA; Knatterud, GL; McMahon, RP; Morgan, NA; Pepine, CJ; Pratt, CM; Sopko, G; Stone, PH | 1 |
| Himeno, E; Kaku, T; Kuroiwa, A; Nakashima, Y | 1 |
| Killip, T | 1 |
| Anderson, RJ; Gottdiener, JS; Massie, BM; Materson, BJ; Reda, DJ; Williams, DW | 1 |
| Conti, CR; Davies, RF; Deanfield, J; Forman, S; Geller, N; Goldberg, AD; Knatterud, GL; Pepine, CJ; Pratt, C; Sopko, G | 1 |
| Bata, I; Fung, A; Goodman, S; Higginson, L; Hill, C; Lam, J; Langer, A; Massel, D; McCans, J; Nasmith, J; Stanton, E; Thompson, C; Warnica, W | 1 |
| Bossi, M; Tiberti, G | 1 |
| Fox, KM; Knight, CJ | 1 |
| Farshi, R; Kistner, D; Longmate, JA; Sarma, JS; Singh, BN | 1 |
| Humphrey, SJ | 1 |
| Berglund, E; Dahlöf, C; Engqvist, L; Lagerstedt, C; Lehtonen, A; Nilsson-Ehle, P; Thulin, T | 1 |
| Cushman, WC; Freis, ED; Lakshman, MR; Materson, BJ; Reda, DJ | 1 |
| Chierchia, SL; Fragasso, G; Margonato, A; Rossetti, E; Xuereb, M; Xuereb, RG | 1 |
| Alov, P; Kastelova, A; Koleva, M | 1 |
| Kristinsson, J; Sigvaldason, K; Snook, CP | 1 |
| Kastelova, A; Koleva, M; Staneva-Stoytcheva, D | 1 |
| Cushman, WC; Materson, BJ; Reda, DJ; Williams, DW | 1 |
| Maniscalco, MM; Newton, W | 1 |
| Ghosh, B; Reddy, LH | 1 |
| Beckerman, B; Brennan, C; Bultas, J; Deanfield, JE; Detry, JM; Lichtlen, PR; Sellier, P; Thaulow, E; Young, ST | 1 |
| Kanorskiĭ, SG; Zingilevskiĭ, KB | 1 |
| Leenen, FH; Ruzicka, M | 1 |
| Fuentes, VL | 1 |
| Safonova, EV; Samoĭlenko, LE; Sergienko, VB; Zharova, EA | 1 |
| Chen, BX; Chen, JZ; Fan, WH; Liu, XJ; Yao, XY; Zhu, JH | 1 |
| Chaitman, BR; Chumakova, G; Kuch, J; Parker, JO; Pepine, CJ; Skettino, SL; Skopal, J; Wang, W; Wolff, AA | 1 |
| Bass, EB; Tamariz, LJ | 1 |
| Gratsianskiĭ, NA | 1 |
| Anwar, A; Bonvini, RF; Hendiri, T | 1 |
| Blagova, OV; Nedostup, AV | 1 |
| Cai, Y; Jia, J; Li, S; Liu, G; Liu, Y; Pan, C; Ren, J; Yu, C | 1 |
| Barbet, I; Goldwater, DR; Kovarik, JM; Lu, M; Maton, S; Riviere, GJ; Schmouder, RL | 1 |
| Ang, PS; Su, DH; Tow, SL | 1 |
| Boughtflower, R; Caldwell, J; Cazenave-Gassiot, A; Hitzel, L; Holyoak, C; Lane, S; Langley, GJ; Oakley, P; Pullen, F; Richardson, S | 1 |
| Lahmers, SM; Reina Doreste, Y; Stern, JA | 1 |
| Kelemen, A; Kónya, Z; Pintye-Hódi, K; Regdon, G; Sipos, B; Sovány, T | 1 |
| Andrews, LM; Koch, BCP; van der Nagel, BCH; van Domburg, B | 1 |
| Ansari, M; Balaei, F; Farhadian, N; Gholami, H; Karami, C; Moradi, S; Shahlaei, M | 1 |
| Chang, H; Chen, C; Du, H; Guan, C; Li, C; Qiu, L; Wang, S; Wang, T; Wu, Y; Zhang, L; Zhang, S; Zhou, H | 1 |
5 review(s) available for diltiazem and atenolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Managing the older patient with hypertension.
Topics: Aged; Aged, 80 and over; Aging; Antihypertensive Agents; Atenolol; Delayed-Action Preparations; Diltiazem; Enalapril; Forecasting; Humans; Hypertension; Randomized Controlled Trials as Topic; Systole | 1993 |
Combination therapy as first-line treatment of arterial hypertension.
Topics: Antihypertensive Agents; Atenolol; Captopril; Diltiazem; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Prazosin; Treatment Outcome | 2002 |
Diastolic function--is this the key to successful management of many feline cardiomyopathies?
Topics: Animals; Atenolol; Cardiomyopathies; Cat Diseases; Cats; Congresses as Topic; Diastole; Diltiazem; Electrocardiography | 2003 |
Pharmacological rate control of atrial fibrillation.
Topics: Amiodarone; Atenolol; Atrial Fibrillation; Cardiotonic Agents; Digoxin; Diltiazem; Heart Rate; Humans; Metoprolol; Randomized Controlled Trials as Topic; Verapamil | 2004 |
39 trial(s) available for diltiazem and atenolol
| Article | Year |
|---|---|
Clinical investigation of asymptomatic cardiac ischemia.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Atenolol; Coronary Artery Bypass; Coronary Disease; Diltiazem; Electrocardiography; Humans; Isosorbide Dinitrate; Myocardial Ischemia; Nifedipine; Pilot Projects; Prognosis | 1991 |
A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women.
Topics: Aged; Atenolol; Blood Pressure; Diltiazem; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Quality of Life | 1991 |
Diltiazem and atenolol in essential hypertension: additivity of effects on blood pressure and cardiac conduction with combination therapy.
Topics: Atenolol; Atrial Natriuretic Factor; Blood Pressure; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Heart Conduction System; Heart Rate; Humans; Hypertension | 1990 |
Effect of atenolol and diltiazem on heart period variability in normal persons.
Topics: Adult; Atenolol; Diltiazem; Electrocardiography, Ambulatory; Female; Heart; Humans; Male; Myocardial Contraction; Myocardial Infarction; Parasympathetic Nervous System; Sympathetic Nervous System | 1991 |
Analysis of time trends, individual subject responses and background variation in crossover factorial studies with antihypertensive drugs.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Diltiazem; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension | 1990 |
Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups.
Topics: Adult; Atenolol; Blood Glucose; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Insulin; Lipoproteins; Male; Middle Aged; Random Allocation | 1989 |
Effects of long-term antihypertensive treatment on glucose metabolism.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus; Diltiazem; Glucose; Humans; Hypertension; Metoprolol; Random Allocation; Risk Factors | 1989 |
Effects of atenolol vs diltiazem on the haemodynamic effects of an inhaled beta 2-adrenoceptor agonist.
Topics: Adult; Atenolol; Blood Pressure; Cardiac Output; Diltiazem; Echocardiography; Fenoterol; Heart Rate; Hemodynamics; Humans; Male; Vascular Resistance | 1989 |
Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol.
Topics: Adult; Atenolol; Blood Pressure; Diltiazem; Half-Life; Heart Rate; Humans; Male; Metoprolol; Propranolol | 1989 |
Exercise capacity and hemodynamics in persons aged 20 to 50 years with systemic hypertension treated with diltiazem and atenolol.
Topics: Adult; Atenolol; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Exercise Test; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Physical Exertion; Random Allocation | 1987 |
Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.
Topics: Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Heart Rate; Humans; Hypertension; Male; Middle Aged; Physical Exertion; Random Allocation | 1987 |
Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension.
Topics: Atenolol; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Electrocardiography; Female; Humans; Hypertension; Male; Middle Aged; Random Allocation | 1987 |
[Comparative anti-ischemic activity of atenolol and diltiazem. Crossed single-blind randomized study using a computerized exercise test].
Topics: Aged; Atenolol; Benzazepines; Clinical Trials as Topic; Computers; Coronary Disease; Diltiazem; Exercise Test; Humans; Male; Middle Aged; Random Allocation | 1985 |
A comparison of diltiazem and atenolol in angina.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Benzazepines; Blood Pressure; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Female; Humans; Male; Middle Aged; Physical Exertion; Pulse | 1985 |
Cardiopulmonary response during exercise of a beta 1-selective beta-blocker (atenolol) and a calcium-channel blocker (diltiazem) in untrained subjects with hypertension.
Topics: Adult; Aged; Atenolol; Blood Pressure; Diltiazem; Double-Blind Method; Exercise; Female; Heart; Heart Rate; Humans; Hypertension; Lung; Male; Middle Aged; Single-Blind Method | 1993 |
Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Calcium Channel Blockers; Circadian Rhythm; Cross-Over Studies; Diltiazem; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Ischemia; Nitroglycerin | 1995 |
Electrophysiologic effects of amlodipine vs. diltiazem in patients with coronary artery disease and beta-blocking therapy.
Topics: Adult; Aged; Amlodipine; Atenolol; Coronary Disease; Diltiazem; Drug Therapy, Combination; Electrophysiology; Female; Heart; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia | 1994 |
Effects of atenolol and diltiazem-SR on exercise and pressure load in hypertensive patients.
Topics: Adult; Aged; Atenolol; Blood Pressure; Diltiazem; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Tolerance; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged | 1994 |
Time-series analysis of long-term ambulatory myocardial ischemia: effects of beta-adrenergic and calcium channel blockade.
Topics: Atenolol; Circadian Rhythm; Cross-Over Studies; Diltiazem; Double-Blind Method; Electrocardiography, Ambulatory; Fourier Analysis; Heart Rate; Humans; Male; Myocardial Ischemia; Signal Processing, Computer-Assisted; Time Factors | 1995 |
The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial.
Topics: Aged; Angina Pectoris; Atenolol; Diltiazem; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Nifedipine; Pilot Projects; Research Design; Time Factors; Treatment Outcome; United States | 1994 |
Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study.
Topics: Aged; Atenolol; Coronary Disease; Diltiazem; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Nifedipine; Pilot Projects; Time Factors; Treatment Outcome; United States | 1994 |
Investigation of therapeutic mechanisms of atenolol and diltiazem in patients with variable-threshold angina.
Topics: Aged; Angina Pectoris, Variant; Atenolol; Blood Pressure; Coronary Angiography; Diltiazem; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Nitrates; Nitroglycerin; Oxygen Consumption | 1994 |
Effects of atenolol and diltiazem on exercise tolerance and ambulatory ischaemia.
Topics: Adult; Angina Pectoris; Atenolol; Chronic Disease; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Exercise; Female; Hemodynamics; Humans; Male; Middle Aged | 1993 |
Comparative effects of different antihypertensive treatments on progression of diabetic renal disease.
Topics: Albuminuria; Antihypertensive Agents; Atenolol; Diabetic Nephropathies; Diltiazem; Dipeptides; Furosemide; Glomerular Filtration Rate; Hemodynamics; Humans; Lisinopril; Middle Aged; Prospective Studies; Renal Circulation | 1993 |
Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Age Factors; Aged; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Captopril; Clonidine; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin | 1993 |
Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study).
Topics: Angina Pectoris; Atenolol; Case-Control Studies; Delayed-Action Preparations; Diltiazem; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Exercise Tolerance; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Pilot Projects; Prospective Studies; Time Factors | 1996 |
Effect of sustained release diltiazem (Diltiazem-R) in patients with stable effort angina.
Topics: Angina Pectoris; Antihypertensive Agents; Atenolol; Cross-Over Studies; Delayed-Action Preparations; Diltiazem; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Systole; Time Factors | 1994 |
Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Captopril; Clonidine; Cohort Studies; Diltiazem; Diuretics; Double-Blind Method; Echocardiography; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardium; Organ Size; Prazosin; Prevalence; Risk Factors; Sodium Chloride Symporter Inhibitors; Treatment Outcome; United States; United States Department of Veterans Affairs | 1997 |
Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.
Topics: Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Atenolol; Calcium Channel Blockers; Cardiopulmonary Bypass; Cardiovascular Diseases; Comorbidity; Diltiazem; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Follow-Up Studies; Humans; Isosorbide Dinitrate; Life Tables; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Nifedipine; Pilot Projects; Prognosis; Risk Factors; Survival Analysis; Treatment Outcome; Vasodilator Agents | 1997 |
PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Calcium Channel Blockers; Death, Sudden, Cardiac; Diltiazem; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Recurrence | 1996 |
Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) Investigators.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Coronary Angiography; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Safety; Treatment Outcome | 1998 |
Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens.
Topics: Aged; Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Calcium Channel Blockers; Circadian Rhythm; Cross-Over Studies; Digoxin; Diltiazem; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise; Female; Follow-Up Studies; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged | 1999 |
Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients. Swedish-Finnish Study Group.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Glucose; Captopril; Diltiazem; Humans; Hypertension; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Quality of Life; Single-Blind Method; Time Factors; Uric Acid | 1999 |
Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Glucose; Captopril; Clonidine; Diltiazem; Diuretics; Double-Blind Method; Hospitals, Veterans; Humans; Hydrochlorothiazide; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Potassium; Prazosin; Time Factors; Treatment Outcome; United States | 1999 |
Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Clonidine; Diastole; Diltiazem; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin; Pressure; Pulse; Randomized Controlled Trials as Topic; Systole; Time Factors; Treatment Outcome | 2001 |
Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Calcium Channel Blockers; Cardiovascular Agents; Coronary Disease; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Isosorbide; Male; Middle Aged; Myocardial Ischemia | 2002 |
[Effects of atenolol and diltiazem-SR on quality of life in the hypertensive patients].
Topics: Adult; Aged; Atenolol; Blood Pressure; Diltiazem; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Quality of Life | 2003 |
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Topics: Acetanilides; Adrenergic beta-Antagonists; Aged; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Cardiovascular Agents; Chronic Disease; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Physical Exertion; Piperazines; Ranolazine; Survival Analysis | 2004 |
The effect on heart rate of combining single-dose fingolimod with steady-state atenolol or diltiazem in healthy subjects.
Topics: Adolescent; Adult; Antihypertensive Agents; Area Under Curve; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diltiazem; Female; Fingolimod Hydrochloride; Heart Rate; Humans; Immunosuppressive Agents; Male; Middle Aged; Propylene Glycols; Receptors, Lysosphingolipid; Single-Blind Method; Sphingosine | 2008 |
60 other study(ies) available for diltiazem and atenolol
| Article | Year |
|---|---|
Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes.
Topics: Absorption; Adsorption; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Permeability; Pharmacokinetics; Spectrophotometry, Ultraviolet | 1998 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Discovery of New Imidazo[2,1-
Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Proliferation; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Drug Stability; Half-Life; Humans; Imidazoles; Melanoma; Mice; Mitogen-Activated Protein Kinase Kinases; Molecular Docking Simulation; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Structure-Activity Relationship; Sulfonamides; Thiazoles; Transplantation, Heterologous | 2021 |
Positive inotropic and negative chronotropic effects of (-)-cis-diltiazem in rat isolated atria.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Atenolol; Calcium; Diltiazem; Endothelium, Vascular; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Potassium Chloride; Quinazolines; Rats; Rats, Inbred Strains; Stereoisomerism; Verapamil | 1992 |
Diltiazem-induced granulomatous hepatitis.
Topics: Aged; Aspirin; Atenolol; Chemical and Drug Induced Liver Injury; Diltiazem; Female; Granuloma; Humans; Liver; Liver Function Tests; Myocardial Infarction | 1991 |
Effects of diltiazem and long-term beta 1-adrenergic blockade on hemodynamics and blood flow during exercise in patients with stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Cardiac Output; Diltiazem; Exercise; Hemodynamics; Humans; Leg; Male; Metoprolol; Middle Aged; Regional Blood Flow; Time Factors | 1990 |
Long-term effects of beta-blockers and Ca2+(+)-antagonists on glucose metabolism.
Topics: Atenolol; Blood Glucose; Diltiazem; Glucose Tolerance Test; Humans; Insulin | 1990 |
Suppression of ventricular premature contractions possibly related to triggered activity by oral diltiazem and atenolol.
Topics: Administration, Oral; Adolescent; Adult; Aged; Atenolol; Cardiac Complexes, Premature; Child; Diltiazem; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Monitoring, Physiologic | 1987 |
Effects of diltiazem and atenolol on exercise performance in man.
Topics: Adult; Atenolol; Diltiazem; Double-Blind Method; Drug Evaluation; Exercise Test; Heart Rate; Humans; Oxygen Consumption; Physical Exertion; Physical Fitness; Time Factors | 1989 |
Comparison of blood pressure response to heat stress in sauna in young hypertensive patients treated with atenolol and diltiazem.
Topics: Adult; Atenolol; Diltiazem; Female; Hemodynamics; Hot Temperature; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologic; Steam Bath; Supination | 1989 |
Complementary mechanisms of atenolol and diltiazem in the clinical improvement of patients with stable angina.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Cardiac Volume; Coronary Circulation; Diltiazem; Exercise Test; Heart Rate; Humans; Middle Aged; Stroke Volume | 1989 |
The acute withdrawal of diltiazem and atenolol: a possible challenge to affective stability.
Topics: Adult; Angina Pectoris; Atenolol; Atrial Flutter; Bipolar Disorder; Diltiazem; Female; Humans; Hypertension; Substance Withdrawal Syndrome | 1989 |
Effects of diltiazem alone or with isosorbide dinitrate or with atenolol both acutely and chronically for stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Diltiazem; Drug Therapy, Combination; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Time Factors | 1989 |
Cardiogenic shock associated with calcium-channel and beta blockers: reversal with intravenous calcium chloride.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Calcium Channel Blockers; Calcium Chloride; Digoxin; Diltiazem; Female; Humans; Isoproterenol; Male; Shock, Cardiogenic; Verapamil | 1985 |
Experimental exercise-induced ischemia: drug therapy can eliminate regional dysfunction and oxygen supply-demand imbalance.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzazepines; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Diltiazem; Dogs; Isosorbide Dinitrate; Models, Biological; Oxygen; Physical Exertion | 1986 |
Regional myocardial blood flow and function in experimental myocardial ischemia.
Topics: Animals; Atenolol; Constriction, Pathologic; Coronary Circulation; Coronary Disease; Coronary Vessels; Diltiazem; Dogs; Electrocardiography; Myocardial Contraction; Physical Exertion | 1986 |
Effect of the combination of diltiazem and atenolol on exercise-induced regional myocardial ischemia in conscious dogs.
Topics: Animals; Atenolol; Benzazepines; Coronary Circulation; Coronary Disease; Diltiazem; Dogs; Drug Therapy, Combination; Hemodynamics; Myocardium; Physical Exertion | 1985 |
Nicardipine may impair glucose metabolism in hypertensive diabetic patients.
Topics: Adult; Aged; Atenolol; Carteolol; Diabetes Mellitus, Type 2; Diltiazem; Enalapril; Female; Glucose; Glycated Hemoglobin; Humans; Hypertension; Male; Metoprolol; Middle Aged; Nicardipine; Propanolamines | 1994 |
Investigation and optimisation of the use of micellar electrokinetic chromatography for the analysis of six cardiovascular drugs.
Topics: Amlodipine; Atenolol; Cardiovascular Agents; Chromatography; Diltiazem; Electrochemistry; Hydrogen-Ion Concentration; Kinetics; Micelles; Nicardipine; Nifedipine; Osmosis; Sodium Dodecyl Sulfate; Verapamil | 1995 |
Chronic beta-blockade does not influence muscle power output during high-intensity exercise of short-duration.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Benzopyrans; Blood Pressure; Cardiovascular Physiological Phenomena; Diltiazem; Ethanolamines; Exercise; Exercise Test; Fatigue; Glycolysis; Humans; Male; Muscle Contraction; Muscles; Myocardial Contraction; Nebivolol; Propranolol; Time Factors | 1993 |
Organic anxiety syndrome after withdrawal of atenolol.
Topics: Aged; Anxiety Disorders; Atenolol; Diltiazem; Humans; Hypertension; Lorazepam; Male; Substance Withdrawal Syndrome; Substance-Related Disorders | 1994 |
[Paroxysmal atrial fibrillation and flutter and "occult" arterial hypertension. The importance of the ambulatory monitoring of the blood pressure. Apropos 2 cases].
Topics: Atenolol; Atrial Fibrillation; Atrial Flutter; Blood Pressure Monitors; Diltiazem; Drug Therapy, Combination; Humans; Hypertension; Lisinopril; Male; Middle Aged; Verapamil | 1993 |
Silent myocardial ischemia: some good news.
Topics: Adrenergic beta-Antagonists; Atenolol; Calcium Channel Blockers; Combined Modality Therapy; Coronary Disease; Death, Sudden, Cardiac; Diltiazem; Electrocardiography; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Nifedipine; Pilot Projects; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome; Vasodilator Agents | 1997 |
[Stable angina pectoris: what is the role of calcium antagonists?].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Diltiazem; Drug Therapy, Combination; Felodipine; Humans; Metoprolol; Multicenter Studies as Topic; Nifedipine; Randomized Controlled Trials as Topic; Verapamil | 1997 |
Cardiovascular and pharmacokinetic interactions between nicorandil and adjunctive propranolol, atenolol or diltiazem in conscious dogs.
Topics: Angina Pectoris; Animals; Atenolol; Blood Pressure; Diltiazem; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Male; Nicorandil; Propranolol; Vasodilator Agents | 1998 |
Long-term preservation of left ventricular function in medically treated patients with coronary artery disease and persistent exercise-induced ischemia.
Topics: Aged; Amlodipine; Anti-Arrhythmia Agents; Atenolol; Cardiovascular Agents; Coronary Disease; Data Interpretation, Statistical; Diastole; Diltiazem; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Exercise Test; Follow-Up Studies; Humans; Middle Aged; Nifedipine; Nitrates; Stroke Volume; Systole; Time Factors; Vasodilator Agents; Ventricular Function, Left | 1999 |
In vitro effects of calcium channel blockers and beta-adrenergic blocking agents on microsomal lipid perocidation and cytochrome p-450 content.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Calcium Channel Blockers; Cytochrome P-450 Enzyme System; Diltiazem; In Vitro Techniques; Lipid Peroxidation; Male; Microsomes, Liver; Nifedipine; Propranolol; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Verapamil | 1999 |
Severe atenolol and diltiazem overdose.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Calcium Channel Blockers; Diltiazem; Drug Interactions; Drug Overdose; Heart Arrest; Humans; Male; Suicide, Attempted; Treatment Outcome | 2000 |
Changes in rat liver monooxygenase activities after administration of atenolol, nifedipine and diltiazem alone and in combination.
Topics: Adrenergic beta-Antagonists; Aminopyrine N-Demethylase; Aniline Hydroxylase; Animals; Atenolol; Calcium Channel Blockers; Cytochrome P-450 Enzyme System; Cytochromes b5; Diltiazem; Drug Therapy, Combination; Ethylmorphine-N-Demethylase; Hexobarbital; Hypnotics and Sedatives; Liver; Male; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Nifedipine; Oxidoreductases; Rats; Rats, Wistar | 2000 |
Does a change to long-acting antianginals provide better symptom control, treatment satisfaction, and quality of life?
Topics: Activities of Daily Living; Adrenergic beta-Agonists; Aged; Angina Pectoris; Atenolol; Delayed-Action Preparations; Diltiazem; Evidence-Based Medicine; Humans; Male; Nitroglycerin; Patient Satisfaction; Practice Guidelines as Topic; Quality of Life; Research Design; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Vasodilator Agents | 2001 |
Effect of physicochemical parameters on skin permeability of antihypertensive.
Topics: Administration, Cutaneous; Animals; Antihypertensive Agents; Atenolol; Chemical Phenomena; Chemistry, Physical; Diltiazem; Female; In Vitro Techniques; Mice; Permeability; Prazosin; Propranolol; Reserpine; Skin | 2001 |
[Comparative effects of amiodarone, diltiazem, and atenolol on results of electrical cardioversion in patients with chronic atrial fibrillation].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Chronic Disease; Diltiazem; Electric Countershock; Female; Humans; Male; Middle Aged; Treatment Outcome | 2002 |
[Preliminary data on combined assessment of tolerance to exercise, left ventricular contractile function in ischemic heart disease patients taking bradycardic agents].
Topics: Atenolol; Bradycardia; Diltiazem; Electrocardiography; Exercise; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Regional Blood Flow | 2003 |
[Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. Results of CARISA].
Topics: Acetanilides; Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Cardiovascular Agents; Chronic Disease; Diltiazem; Double-Blind Method; Exercise Test; Humans; Multicenter Studies as Topic; Piperazines; Placebos; Randomized Controlled Trials as Topic; Ranolazine; Time Factors; Vasodilator Agents | 2004 |
Sinus arrest and moderate hyperkalemia.
Topics: Antihypertensive Agents; Arrhythmia, Sinus; Atenolol; Biphenyl Compounds; Bradycardia; Depression, Chemical; Diltiazem; Female; Heart Arrest; Heart Rate; Humans; Hyperkalemia; Irbesartan; Middle Aged; Tetrazoles | 2006 |
[Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Atrioventricular Node; Calcium Channel Blockers; Diltiazem; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Treatment Outcome; Ventricular Fibrillation; Verapamil | 2006 |
Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography--tandem mass spectrometry.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, Liquid; Diltiazem; Humans; Metoprolol; Mexiletine; Molecular Structure; Propanolamines; Propranolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry; Verapamil | 2007 |
Bilateral posterior ischemic optic neuropathy associated with use of sildenafil.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Drugs, Chinese Herbal; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypotension; Male; Optic Nerve; Optic Neuropathy, Ischemic; Phosphodiesterase Inhibitors; Piperazines; Purines; Retinal Artery; Risk Factors; Sildenafil Citrate; Simvastatin; Sulfones; Vision, Low | 2008 |
Effect of increasing concentration of ammonium acetate as an additive in supercritical fluid chromatography using CO2-methanol mobile phase.
Topics: Acetates; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Atenolol; Carbon Dioxide; Chromatography, High Pressure Liquid; Chromatography, Supercritical Fluid; Diltiazem; Mass Spectrometry; Methanol; Naproxen; Pyridines; Silicon Dioxide; Sulfonamides; Surface Properties | 2009 |
ECG of the month. Multiple episodes of collapse in a cat.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Aspirin; Atenolol; Calcium Channel Blockers; Cat Diseases; Cats; Diltiazem; Electrocardiography; Male; Platelet Aggregation Inhibitors | 2013 |
Physicochemical characterisation and investigation of the bonding mechanisms of API-titanate nanotube composites as new drug carrier systems.
Topics: Atenolol; Calorimetry, Differential Scanning; Diclofenac; Diltiazem; Drug Carriers; Drug Liberation; Hydrochlorothiazide; Microscopy, Electron, Scanning; Nanotubes; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; Thermogravimetry; Titanium | 2017 |
High-throughput quantification of ten antiarrhythmic drugs in human plasma using UPLC-MS/MS.
Topics: Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carvedilol; Chromatography, High Pressure Liquid; Diltiazem; Flecainide; High-Throughput Screening Assays; Humans; Lidocaine; Metoprolol; Propranolol; Reproducibility of Results; Sotalol; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Verapamil | 2019 |
A study on the protease activity and structure of pepsin in the presence of atenolol and diltiazem.
Topics: Atenolol; Binding Sites; Catalytic Domain; Diltiazem; Humans; Hydrogen Bonding; Molecular Docking Simulation; Pepsin A; Peptide Hydrolases; Protein Binding; Spectrometry, Fluorescence; Structure-Activity Relationship | 2020 |
Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats.
Topics: Animals; Antipyrine; Atenolol; Carbamazepine; Cell Membrane; Digoxin; Diltiazem; Diphenhydramine; Drug Elimination Routes; Gabapentin; Lamotrigine; Liver; Memantine; Membrane Transport Proteins; Microdialysis; Muscle, Skeletal; Ofloxacin; Pharmaceutical Preparations; Propranolol; Pyrilamine; Quinidine; Rats; Terfenadine | 2021 |